190 related articles for article (PubMed ID: 20003162)
1. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
Chu YT; Chang TT; Jong YJ; Kuo PL; Lee HM; Lee MS; Chang HW; Hung CH
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162
[TBL] [Abstract][Full Text] [Related]
2. Long-acting beta 2 agonists suppress IP-10 expression in human bronchial epithelial cells.
Chien JW; Chu YT; Yang SN; Kuo CH; Wang WL; Kuo PL; Jong YJ; Hung CH
J Investig Med; 2012 Oct; 60(7):1048-53. PubMed ID: 22914602
[TBL] [Abstract][Full Text] [Related]
3. Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells.
Hung CH; Chu YT; Hua YM; Hsu SH; Lin CS; Chang HC; Lee MS; Jong YJ
Eur Respir J; 2008 Jun; 31(6):1313-21. PubMed ID: 18256057
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
[TBL] [Abstract][Full Text] [Related]
5. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Aziz I; Lipworth BJ
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells.
Chiu JC; Hsu JY; Fu LS; Chu JJ; Chi CS
J Microbiol Immunol Infect; 2007 Oct; 40(5):388-94. PubMed ID: 17932597
[TBL] [Abstract][Full Text] [Related]
7. Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells.
Strandberg K; Palmberg L; Larsson K
Respir Med; 2007 Jun; 101(6):1132-9. PubMed ID: 17229563
[TBL] [Abstract][Full Text] [Related]
8. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids.
Pang L; Knox AJ
FASEB J; 2001 Jan; 15(1):261-269. PubMed ID: 11149914
[TBL] [Abstract][Full Text] [Related]
9. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
Anderson GP
Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
Lindén A; Rabe KF; Löfdahl CG
Lung; 1996; 174(1):1-22. PubMed ID: 8746998
[TBL] [Abstract][Full Text] [Related]
11. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Chinese herb extract osthol on IL-4-induced eotaxin expression in BEAS-2B cells.
Chiu PR; Lee WT; Chu YT; Lee MS; Jong YJ; Hung CH
Pediatr Neonatol; 2008 Aug; 49(4):135-40. PubMed ID: 19054919
[TBL] [Abstract][Full Text] [Related]
13. Berberine Inhibits Pro-inflammatory Cytokine-induced IL-6 and CCL11 Production via Modulation of STAT6 Pathway in Human Bronchial Epithelial Cells.
Ma J; Chan CC; Huang WC; Kuo ML
Int J Med Sci; 2020; 17(10):1464-1473. PubMed ID: 32624703
[TBL] [Abstract][Full Text] [Related]
14. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
15. Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.
van der Woude HJ; Aalbers R
Am J Respir Med; 2002; 1(1):55-74. PubMed ID: 14720076
[TBL] [Abstract][Full Text] [Related]
16. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements.
Edwards MR; Haas J; Panettieri RA; Johnson M; Johnston SL
J Biol Chem; 2007 May; 282(21):15366-75. PubMed ID: 17395587
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
19. Long-acting inhaled beta2-agonists in asthma therapy.
Moore RH; Khan A; Dickey BF
Chest; 1998 Apr; 113(4):1095-108. PubMed ID: 9554653
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta 2-agonists.
Tattersfield AE
Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
